Eternal BiolabsResearch Desk

Study summary · KPV

Lysine-Proline-Valine Peptide Mitigates Fine Dust-Induced Keratinocyte Apoptosis and Inflammation by Regulating Oxidative Stress and Modulating the MAPK/NF-κB Pathway

Life Sciences (ScienceDirect/Elsevier) · 2025 · Summarised by the Eternal Biolabs Research Desk

Plain-language summary

This study investigated KPV, the C-terminal tripeptide of alpha-melanocyte stimulating hormone, against particulate matter (PM10)-induced oxidative damage and inflammation in human HaCaT keratinocytes. KPV treatment restored cell viability, reduced IL-1β secretion, and blocked ROS-mediated caspase-1 activation in cells stressed by PM10 exposure. In a 3D skin model, KPV effectively attenuated inflammatory cell death induced by PM10, pointing to its potential as a protective agent against environmental pollutant-related skin damage.

Source & related

Cite this page

Eternal Biolabs Research Desk (2026). Lysine-Proline-Valine Peptide Mitigates Fine Dust-Induced Keratinocyte Apoptosis and Inflammation by Regulating Oxidative Stress and Modulating the MAPK/NF-κB Pathway. Eternal Biolabs. https://eternalbiolabs.ca/api/g/study/7c4d682c-edf1-44ec-b660-76bbe9c339cc Last reviewed 2026-10-03.

For laboratory research use only. Nothing on this page is medical advice, dosing guidance, or an instruction for human or veterinary use.